Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae

被引:16
|
作者
Jorgensen, JH
Crawford, SA
McElmeel, ML
Whitney, CG
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[2] Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA
关键词
D O I
10.1128/AAC.48.2.605-607.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of two investigational ketolides, cethromycin (formerly ABT-773) and telithromycin, were determined for a selected group of 312 Streptococcus pneumoniae isolates from a national surveillance program. The MIC of cethromycin at which 50% of the isolates were inhibited was 0.008 mug/ml, and the MIC at which 90% of the isolates were inhibited was 0.06 mug/ml; the corresponding values for telithromycin were less than or equal to0.015 and 0.25 mug/ml, respectively. For six quinupristin-dalfopristin-resistant strains, the cethromycin MICs were 0.25 to 16 mug/ml and the telithromycin MICs were 1 to 4 mug/ml. However, there was only 0.3% resistance to telithromycin.
引用
收藏
页码:605 / 607
页数:3
相关论文
共 50 条
  • [21] Levofloxacin in vitro activities bacteremic isolates of Streptococcus pneumoniae
    Plouffe, JF
    Baird, I
    Barnishan, J
    PorterfieldBaxa, J
    Best, M
    Dalieh, S
    Emerick, J
    Fass, RJ
    Gianakopoulos, G
    Hackman, BA
    Hadley, S
    Herbert, M
    Koletar, SL
    Maher, W
    Minor, JA
    Oglevee, BA
    Para, MF
    Parsons, J
    Rogers, T
    ScottTibbs, G
    Tumbleson, CS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (01) : 43 - 45
  • [22] A comparative in vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America
    Hoban, DJ
    Bouchillon, SK
    Karlowsky, JA
    Johnson, JL
    Butler, DL
    Miller, LA
    Poupard, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3008 - 3011
  • [23] In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations
    Farrell, DJ
    Morrissey, I
    Bakker, S
    Buckridge, S
    Felmingham, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 3169 - 3171
  • [24] Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections
    Bingen, E
    Doit, C
    Loukil, C
    Brahimi, N
    Bidet, P
    Deforche, D
    Geslin, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2345 - 2347
  • [25] Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae:: Results of two years of the PROTEKT surveillance study
    Schito, GC
    Marchese, A
    Elkharrat, D
    Farrell, DJ
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (01) : 13 - 22
  • [26] Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and in vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae
    Kim, NJ
    Park, SJ
    Choi, SH
    Lee, MS
    Choo, EJ
    Kwak, YG
    Woo, JH
    Ryu, J
    Jeong, JY
    Kim, YS
    MICROBIAL DRUG RESISTANCE, 2005, 11 (03) : 260 - 265
  • [27] Activity of faropenem against resistant isolates of Streptococcus pneumoniae
    Black, JA
    Moland, ES
    Chartrand, SA
    Thomson, KS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 41 (1-2) : 89 - 92
  • [28] Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae
    Johnson, AP
    Warner, M
    Parsons, T
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (08) : 622 - 623
  • [29] Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers
    Bozdogan, B
    Appelbaum, PC
    Kelly, LM
    Hoellman, DB
    Tambic-Andrasevic, A
    Drukalska, L
    Hryniewicz, W
    Hupkova, H
    Jacobs, MR
    Kolman, J
    Konkoly-Thege, M
    Miciuleviciene, J
    Pana, M
    Setchanova, L
    Trupl, J
    Urbaskova, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 653 - 661
  • [30] In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae
    Okamoto, H
    Miyazaki, S
    Tateda, K
    Ishii, Y
    Yamaguchi, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3250 - 3252